Changzhou Second People's Hospital-Cardiology ( Site 3459)

Changzhou, Jiangsu 213000

0 studies enrolling now · 1 studies all time

What they study most

Arteriosclerosis, Hypercholesterolaemia

Studies at this site

• Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes — Running, not enrolling